14-49634078-C-T

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_018139.3(DNAAF2):​c.1072G>A​(p.Ala358Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000391 in 1,536,082 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000041 ( 0 hom. )

Consequence

DNAAF2
NM_018139.3 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: -5.25

Publications

0 publications found
Variant links:
Genes affected
DNAAF2 (HGNC:20188): (dynein axonemal assembly factor 2) This gene encodes a highly conserved protein involved in the preassembly of dynein arm complexes which power cilia. These complexes are found in some cilia and are assembled in the cytoplasm prior to transport for cilia formation. Mutations in this gene have been associated with primary ciliary dyskinesia. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2009]
DNAAF2 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 10
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.040427744).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAAF2NM_018139.3 linkc.1072G>A p.Ala358Thr missense_variant Exon 1 of 3 ENST00000298292.13 NP_060609.2 Q9NVR5-1
DNAAF2NM_001083908.2 linkc.1072G>A p.Ala358Thr missense_variant Exon 1 of 2 NP_001077377.1 Q9NVR5-2
DNAAF2NM_001378453.1 linkc.-800G>A upstream_gene_variant NP_001365382.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAAF2ENST00000298292.13 linkc.1072G>A p.Ala358Thr missense_variant Exon 1 of 3 1 NM_018139.3 ENSP00000298292.8 Q9NVR5-1
DNAAF2ENST00000406043.3 linkc.1072G>A p.Ala358Thr missense_variant Exon 1 of 2 1 ENSP00000384862.3 Q9NVR5-2

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152052
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000457
AC:
6
AN:
131386
AF XY:
0.0000419
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000172
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000430
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000412
AC:
57
AN:
1384030
Hom.:
0
Cov.:
88
AF XY:
0.0000513
AC XY:
35
AN XY:
682248
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30916
American (AMR)
AF:
0.000145
AC:
5
AN:
34448
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24748
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35342
South Asian (SAS)
AF:
0.00
AC:
0
AN:
78448
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
43352
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4450
European-Non Finnish (NFE)
AF:
0.0000474
AC:
51
AN:
1074928
Other (OTH)
AF:
0.0000174
AC:
1
AN:
57398
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152052
Hom.:
0
Cov.:
33
AF XY:
0.0000135
AC XY:
1
AN XY:
74256
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41440
American (AMR)
AF:
0.00
AC:
0
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10540
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68000
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000453

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Uncertain:2
Nov 17, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1072G>A (p.A358T) alteration is located in exon 1 (coding exon 1) of the DNAAF2 gene. This alteration results from a G to A substitution at nucleotide position 1072, causing the alanine (A) at amino acid position 358 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Jul 24, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 358 of the DNAAF2 protein (p.Ala358Thr). This variant is present in population databases (no rsID available, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with DNAAF2-related conditions. ClinVar contains an entry for this variant (Variation ID: 411174). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
0.031
DANN
Benign
0.91
DEOGEN2
Benign
0.0034
T;.
Eigen
Benign
-1.9
Eigen_PC
Benign
-2.1
FATHMM_MKL
Benign
0.0073
N
LIST_S2
Benign
0.45
T;T
M_CAP
Benign
0.0013
T
MetaRNN
Benign
0.040
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.90
L;L
PhyloP100
-5.3
PrimateAI
Uncertain
0.69
T
PROVEAN
Benign
-0.10
N;N
REVEL
Benign
0.0030
Sift
Benign
0.047
D;T
Sift4G
Benign
0.69
T;T
Polyphen
0.0040
B;B
Vest4
0.059
MutPred
0.30
Loss of helix (P = 0.0068);Loss of helix (P = 0.0068);
MVP
0.072
MPC
0.49
ClinPred
0.13
T
GERP RS
-8.8
Varity_R
0.030
gMVP
0.32
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1060503179; hg19: chr14-50100796; API